An open label study to evaluate the effect of CellCept [mycophenolate mofetil] in combination wth cyclosporine A and steroids on renal function and the prevention of acute rejection in heart transplant patients

Trial Profile

An open label study to evaluate the effect of CellCept [mycophenolate mofetil] in combination wth cyclosporine A and steroids on renal function and the prevention of acute rejection in heart transplant patients

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Dec 2014

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Ciclosporin; Corticosteroids
  • Indications Heart transplant rejection
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 17 Mar 2014 New source identified and integrated (ClinicalTrial.gov; NCT02091414)
    • 19 Sep 2008 Status changed from active, no longer recruiting to completed, as reported by Roche.
    • 10 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top